K. Murakami-Mori

发表

Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA/ionomycin.

S. Nakamura, B. Bonavida, A. Jewett, 1998, International journal of oncology.

Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.

L. Lai, M. Tong, K. Murakami-Mori, 1997, The Western journal of medicine.

Molecular pathogenesis of AIDS-associated Kaposi's sarcoma: growth and apoptosis.

B. Bonavida, S. Mori, K. Murakami-Mori, 2000, Advances in cancer research.

Endogenous basic fibroblast growth factor is essential for cyclin E-CDK2 activity in multiple external cytokine-induced proliferation of AIDS-associated Kaposi's sarcoma cells: dual control of AIDS-associated Kaposi's sarcoma cell growth and cyclin E-CDK2 activity by endogenous and external signals.

S. Nakamura, S. Mori, K. Murakami-Mori, 1998, Journal of immunology.

Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells.

S. Nakamura, B. Bonavida, S. Mori, 1999, Journal of immunology.

AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.

S. Nakamura, T. Kishimoto, T. Taga, 1995, The Journal of clinical investigation.

Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis.

S. Nakamura, B. Bonavida, A. Jewett, 1996, Cancer research.

The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent

B. Bonavida, A. Jewett, S. Mori, 1997, Cancer Immunology, Immunotherapy.

Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D.

S. Nakamura, A. Ashkenazi, B. Bonavida, 1999, Journal of immunology.

Actinomycin D to Apo-2 Ligand-Induced Apoptosis by Sensitization of AIDS-Kaposi ' s Sarcoma Cells

A. Ashkenazi, B. Bonavida, Shuji Nakamura, 1999 .

Endogenous and External Signals Growth and Cyclin E-CDK2 Activity by AIDS-Associated Kaposi's Sarcoma Cell Sarcoma Cells: Dual Control of Proliferation of AIDS-Associated Kaposi's Multiple External Cytokine-Induced Is Essential for Cyclin E-CDK2 Activity in Endogenous Basic Fibroblast Growth Factor

Shuji Nakamura, S. Mori, K. Murakami-Mori, 1998 .

Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells.

B. Bonavida, S. Mori, K. Murakami-Mori, 1999, Biochemical and biophysical research communications.

Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.

B. Bonavida, S. Mori, K. Murakami-Mori, 1999, Anticancer research.

Short report: herpes-like DNA sequences in African-endemic and acquired immunodeficiency syndrome-associated Kaposi's sarcoma.

S. Nakamura, K. Toriyama, K. Murakami-Mori, 1996, The American journal of tropical medicine and hygiene.

p38MAP kinase is a negative regulator for ERK1/2-mediated growth of AIDS-associated Kaposi's sarcoma cells.

S. Nakamura, Shuji Nakamura, S. Mori, 1999, Biochemical and biophysical research communications.

Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.

S. Nakamura, B. Rajeev, H. Weich, 1997, Journal of immunology.

The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.

S. Nakamura, T. Kishimoto, T. Taga, 1996, International immunology.

Dexamethasone enhances expression of membrane and soluble interleukin-6 receptors by prostate carcinoma cell lines.

B. Bonavida, S. Mori, K. Murakami-Mori, 1998, Anticancer Research.